Switch to:
More From Other Websites
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Feb 26 2015
Alkermes Falls on Pipeline News; Q4 Earnings Plunge Y/Y - Analyst Blog Feb 25 2015
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care... Feb 24 2015
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care... Feb 24 2015
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care... Feb 24 2015
Alkermes shares down after it stops development of pain pill Feb 24 2015
Alkermes beats Street 4Q forecasts Feb 24 2015
Alkermes beats Street 4Q forecasts Feb 24 2015
Jim Cramer: Use Share Weakness to Buy Alkermes for Its Drug Pipeline Feb 24 2015
Waiting for Yellen Q&A, but QE helping elsewhere Feb 24 2015
Alkermes Plc Earnings Call scheduled for 8:30 am ET today Feb 24 2015
Alkermes To Discontinue Development of Pain Treatment Feb 24 2015
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial... Feb 24 2015
ALKERMES PLC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 24 2015
Q4 2014 Alkermes Plc Earnings Release - Before Market Open Feb 24 2015
Alkermes Announces Results From Phase 1 Study of ALKS 7106 Feb 24 2015
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial... Feb 24 2015
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial... Feb 24 2015
Alkermes Announces Results From Phase 1 Study of ALKS 7106 Feb 24 2015
Alkermes Announces Results From Phase 1 Study of ALKS 7106 Feb 24 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK